In addition to the classical nuclear estrogen receptor, the expression of non-nuclear estrogen receptors localized to the cell surface membrane (mER) has recently been demonstrated. Estrogen and its receptors have been implicated in the development or progression of numerous neurodegenerative disorders. Furthermore, the pathogenesis of these diseases has been associated with disturbances of two key cellular programs: apoptosis and autophagy. An excess of apoptosis or a defect in autophagy has been implicated in neurodegeneration. The aim of this study was to clarify the role of ER in determining neuronal cell fate and the possible implication of these receptors in regulating either apoptosis or autophagy. The human neuronal cell line SH-SY5Y and mouse neuronal cells in primary culture were thus exposed to chronic minimal peroxide treatment (CMP), a form of subcytotoxic minimal chronic stress previously that mimics multiple aspects of longterm cell stress and represents a limited molecular proxy for neurodegenerative processes. We actually found that either E2 or E2-bovine serum albumin construct (E2BSA, i.e. a non-permeant form of E2) was capable of modulating intracellular cell signals and regulating cell survival and death. In particular, under CMP, the up-regulation of mERa, but not mERb, was associated with functional signals (ERK phosphorylation and p38 dephosphorylation) compatible with autophagic cytoprotection triggering and leading to cell survival. The mERa trafficking appeared to be independent of the microfilament system cytoskeletal network but was seemingly associated with microtubular apparatus network, i.e., to MAP2 molecular chaperone. Importantly, antioxidant treatments, administration of siRNA to ERa, or the presence of antagonist of ERa hindered these events. These results support that the surface expression of mERa plays a pivotal role in determining cell fate, and that ligand-induced activation of mER signalling exerts a powerful cell-survival signal. These results shed new light on the pathogenetic mechanisms leading to neuronal cell degeneration.
Introduction
Several lines of evidence indicate that 17b-estradiol (E2) directly modulates the development and function of neurons, although the mechanism(s) by which this might occur is not well understood [1] [2] [3] . The primary mechanism of E2 activity is mediated by transcriptional actions of the intracellular, nuclear estrogen receptors (nER), ERa and ERb, to produce genomic effects. A variety of cellular responses to physiological concentrations of E2 occurs rapidly, within seconds to few minutes, so that they cannot be mediated by transcription and protein synthesis. These rapid estrogen-mediated effects (referred to as ''nongenomic'') are triggered through the activation of non-nuclear membraneassociated ER (mER) [4] [5] [6] [7] [8] . These receptors are structurally similar to their intracellular counterparts and, after ligand binding, they activate various protein kinase cascades, including extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK), protein kinase A, protein kinase C, Akt, and phosphatidylinositol 3-OH kinase (PI3K) [5] . The effects of E2 in the brain are mainly mediated by the nuclear ER-mediated genomic signaling pathway, which seems to exert a cytoprotective activity, e.g. increasing the expression of the anti apoptotic molecule Bcl-2 in hippocampal neurons in culture [9] [10] [11] . In addition, it has been suggested that the E2-dependent nongenomic signaling, by hindering apoptotic cell death, mediates neuroprotection and preservation of cognitive function following global cerebral ischemia, supporting a potentially important role of nonnuclear mER [12] . In this regard, the expression levels of mERa and mERb, acting independently from nuclear ER, have been demonstrated to trigger a functional and prompt cell response. This appears to play a key role in mediating estrogen's effects: an increased expression of mERa has to be considered as protective whereas an increased expression of mERb leads to cell demise [13] . In particular, a decreased ERa:ERb ratio might trigger a rapid phosphorylation of p38 MAPK, which in turn phosphorylates the p53 tumor suppressor and accelerates apoptosis rate [14] . A further actor in this complex scenario is represented by autophagy, a cytoprotective mechanism characterized by the ability of the cell to respond to metabolic stress by recycling damaged materials or organelles in vacuoles, i.e. autophagolysosomes, and leading to cell survival [15] [16] [17] [18] [19] . Autophagic vacuolar flux is precisely regulated by a complex cascade of events and also involves ERK/MAPK and p38 pathways, two well-known estrogen-activated signaling cascades [20] .
Apart from physiological processes, estrogen has also been implicated in the development or progression of numerous neurodegenerative disorders, including stroke, Alzheimer's disease and Parkinson's disease. Although the precise role of ER in these diseases has scarcely been investigated, either apoptosis or autophagy have been suggested to play a pathogenetic role [21] . The aim of this study is to clarify the role of intracellular and cell surface ER in determining neuronal cell fate and the possible implication of these receptors in regulating either apoptosis or autophagy in neuronal cells under chronic minimal peroxide (CMP) treatment. This is a form of subcytotoxic minimal chronic stress recently proposed as a useful tool for the investigation of neuronal cell degeneration pathways [22] . In fact, CMP treatment at multiple levels is able to e strongly recapitulate multiple aspects of long-term cell stress and as such, it represents a limited molecular proxy for neurodegenerative processes [22] . We first investigated the expression of intracellular (nER) and cell surface ERa and ERb in two cell models, i.e., the human neuronal cell line SH-SY5Y and primary cultures of rat hippocampal neurons, both representing key cell systems for the studies on neurodegenerative diseases. We then investigated whether under protracted, tolerable oxidative injury, such as CMP, E2 and E2-albumin construct (E2BSA), the non-permeant form of E2, were capable of modulating cell signals and regulating cell survival or death.
Results

CMP induces up-regulation of surface ERa
We first investigated the expression of ER in physiological condition and after a chronic minimal peroxide (CMP) stress as stated elsewhere [22] (see Materials and Methods). Flow cytometry analysis clearly showed that both the isoforms of ER, i.e., ERa and ERb, were expressed at intracellular level in SH-SY5Y neuronal cells without significant differences between each other (positivity for ER expression was evaluated using the Kolmogorov-Smirnov analysis, Figure 1A , left panels). CMP treatment did not influence intracellular ER expression ( Figure 1B) . On the basis of literature demonstrating the presence of functional ER at the surface membrane of cells of different histotypes [23] [24] [25] [26] , we evaluated the cell surface expression of mER. This analysis revealed that both mERa and mERb were undetectable on SH-SY5Y untreated cells ( Figure 1A , right panels). Conversely, under CMP-induced stress, mERa expression was observed on SH-SY5Y cells whereas mERb expression remained undetectable ( Figure 1C,D) . Since CMP induced reactive oxygen species (ROS) generation and a mild oxidative imbalance in the cell cytoplasm [22] , we decided to evaluate the possible implication of ROS generation in the upmodulation of mERa by pre-treating SH-SY5Y cells with Nacetyl-L-cysteine (NAC). This compound is known to exert an antioxidant activity by acting as a thiol group supplier [27] . The results of these experiments clearly indicated that pre-treatment of cells with NAC before CMP-induced stress prevented CMPinduced upregulation of mERa ( Figure 1C,D) . The mERa expression was also evaluated by immunofluorescence microscopy at high magnification in unpermeated cells (Figure 2) . Consistent with the results obtained by flow cytometry, immunofluorescence microscopy failed to reveal mERa in untreated cells (Figure 2A) , whereas clearly displayed the presence of mERa at the surface of CMP-treated cells ( Figure 2B , note the punctate green fluorescence). Additionally, mERa expression was markedly reduced in NAC/CMP-treated cells ( Figure 2C ). Since SH-SY5Y cells have to be considered as highly proliferating cells of tumor origin, we further evaluated the expression of mERa in differentiated neurons (primary cultures of rat hippocampal neurons at DayIn-Vitro, DIV, 14) . Hippocampal neurons at DIV 14 are highly polarized cells, with distinct compartmentalization of cytoskeletal elements in the dendritic and axonal domains. Similar results were obtained with these primary cells compared to those obtained with SH-SY5Y cells, in that the surface expression of mERa was undetectable in untreated ( Figure 3A) and in NAC/CMP-treated ( Figure 3D ) cells and detectable in CMP-treated cells ( Figure 3B ,C). Since recent evidence highlights the relationship between extra-nuclear signaling of ERa and the cytoskeleton in the central nervous system [28] , we investigated the expression of cytoskeleton proteins and their possible colocalization with mERa in neuronal cells under CMP treatment. In particular, we labeled these cells for neuronal-specific microtubule associated protein (MAP)2 [29] and actin microfilaments. Both SH-SY5Y cells and rat hippocampal neurons were positive to MAP2 (Figure 2A and 3A respectively, red fluorescence) and the expression of this protein was partially overlaid to that of mERa (yellow spots, Figure 2B , 3B). Of note, the mERa expression was particularly evident in MAP2-positive somatodendritic compartment ( Figure 3C) . Control experiments were also performed on actin microfilaments, which allowed us to assess the integrity of neuritic tree. CMP treatment did not induce alteration of the dendritic trees although some actin filament interruptions and fragmentations were detectable ( Figure S1 ). No positivity for mERa was detectable along non-dendritic actin filaments.
mERa modulates cell survival signals
Based on the results reported above, an important point was to evaluate whether mER were functional receptors. To provide evidence of a signaling function for estrogen via mER on neuronal cells, we determined in SH-SY5Y cells the effect of a membrane non-permeant form of E2 (E2BSA) and, as a control, of a membrane permeant E2 form, on the activation of two key molecules involved in protein kinase cascades regulating cell homeostasis: ERK and p38 MAPK. The first is involved in functions including the regulation of mitosis and post-mitotic functions in differentiated cells [30] , whilst the second is involved in cell differentiation and apoptosis [31] . We found that in physiological conditions, estrogen (either E2BSA or E2) did not affect ERK phosphorylation (p-ERK) level ( Figure 4A ). Conversely, under CMP treatment both non-permeant and permeant forms of E2 significantly increased p-ERK levels (ratio p-ERK/bactin, 0.860.05% vs 1.360.1 for E2BSA treatment, and 0.860.05 vs 1.460.1 for E2 treatment P,0.01 in both cases, see Figure 4A ). Regarding p38 phosphorylation (p-p38), treatment with both nonpermeant and permeant forms of E2 did not influence p-p38 level (data not shown). Interestingly, E2BSA exposure (30 min) was capable of preventing the increase of p-p38 induced by CMP treatment (ratio p-p38/b-actin, 1.860.1% vs 0.860.1, P,0.01, Figure 4B ).
Estrogen effects on cell fate
Based on the results reported above, we decided to evaluate whether estrogen, acting through the mERa, could modulate two major cell processes determining cell survival or death: apoptosis and autophagy.
mERa ligation hinders apoptosis
We evaluated the role of estrogen in modulating apoptosis in different experimental conditions ( Figure 5 ). We found that in physiological conditions E2 and E2BSA did not affect apoptosis of SH-SY5Y cells. By contrast, after CMP treatment, the percentage of apoptosis, as expected, was significantly increased (P,0.001, Figure 5A ,B), although the subcytotoxic experimental conditions used here did not affect cell proliferation and cell cycle progression ( Figure S2 ). Interestingly, estrogen exposure was capable of preventing the increase of apoptosis induced by CMP treatment (1862% vs 861% for E2BSA treatment and 1862% vs 761% for E2 treatment, P,0.01 in both cases, Figure 5A ,B). We also analyzed the expression of the key anti-apoptotic protein Bcl2. Concordant with the above results, we found that the level of this protein (expressed as mean fluorescence intensity, MFI) was significantly decreased in SH-SY5Y cells under CMP treatment in comparison with untreated cells (P,0.01), but both E2BSA and E2 were able to prevent this decrease (P,0.01, Figure 5C ). Hence, mERa activation can support functional survival signals inside the cells.
mERa ligation induces autophagy
Autophagy is an essential cytoprotective mechanism contributing to neuronal cell homeostasis [32] . A critical event in autophagy is the conversion of microtubule-associated protein 1 light chain 3 (LC3) from the free LC3-I form to the membrane-bound LC3-II form. Therefore the level of this form of LC3 is a good quantification for autophagy [33] . In physiological conditions, we found that estrogen did not affect the LC3-II levels in SH-SY5Y cells ( Figure 5D ,E). After CMP treatment LC3-II appeared unchanged, but it significantly increased after both non-permeant and permeant estrogen exposure (ratio LC3-II/bactin, 160.2 vs 1.560.3 under CMP and E2BSA treatment and 160.2 vs 1.660.3 under CMP and E2 treatment, P,0.01 in both cases, Figure 5D ,E). To demonstrate that estrogen administration can induce autophagy as cytoprotection mechanism, we inhibited autophagy using 3-methyl adenine (3-MA), an inhibitor of type III phosphatidylinositol 3-kinases that blocks autophagosome formation [34] . In the presence of 3-MA, E2BSA failed to protect cells under CMP treatment from cell death so that ''normal'' apoptotic susceptibility was restored ( Figure 5F ). As expected, in CMP-treated SH-SY5Y cells, E2BSA in presence of 3-MA did not induce the increase of LC3-II level ( Figure 5G ).
mERa inhibition and knockdown hinders estrogen mediated effects
Finally, in order to clarify the role of mERa in estrogenmediated autophagy, we treated SH-SY5Y cells with a specific ERa antagonist (methyl-piperidino-pyrazole, MPP) or transfected them with ERa siRNA. Pre-treatment with MPP inhibited the protective activity exerted by E2BSA, restoring apoptotic susceptibility ( Figure 5B) . Fittingly, MPP treatment also decreased significantly E2BSA-induced autophagy, detectable under CMP treatment ( Figure 6A,B) . In ERa silencing experiments, we found a significant reduction of mERa surface expression in transfected cells with respect to non-silencing siRNA transfected cells (MFI for mERa expression: 1.460.2 vs 1.160.2, P,0.01, Figure 6C ). In CMP-treated cells, knocking down ERa significantly attenuated E2BSA-mediated enhancement of autophagy (1.460.1 vs 1.260.2 P,0.01, Figure 6D ,E). These results suggest a regulatory role for mERa in cell ''fate'' modulation. 
Discussion
In this study, we show that under a condition of protracted, tolerable oxidative imbalance, ERa, but not ERb, was expressed at the surface of SH-SY5Y, a neuroblastoma cell line considered as a paradigmatic model of dopaminergic neurons, and of rat hippocampal primary neurons. Importantly, this stress-associated upregulation of mERa at the cell surface could provide important survival signals to the neuronal cells. Its agonist, i.e. non-permeant E2, was in fact able to trigger various intracellular signals, including ERK phosphorylation and p38 inhibition, leading to an inhibition of apoptotic cell death and igniting cell cytoprotection by autophagy. The abrogation of these effects by pretreatment with an ERa antagonist and by transfection with specific siRNA clearly indicated the involvement of ERa in the neuroprotective mechanism mediated by estrogens.
The first point to consider is that, under CMP, neuronal cells can up-regulate mER. In particular, under chronic sublethal stress somewhat mimicking chronic inflammation, neuronal cells express at their surface mERa but not mERb. This could be relevant in the maintenance of cell homeostasis. In fact, while mERa ligation has been hypothesized to be associated with cell survival signals, mERb ligation was associated with cell death by apoptosis [13] . This would be consistent with a variety of other circumstances where ERa and ERb have been shown to exhibit opposing actions. Hence, it seems conceivable that the mERa up-regulation detectable in CMP-treated cells could provide the cell with a mechanism to counteract subcellular modifications triggered by CMP conditions, including mild oxidative alterations. In fact, administration of NAC, which is known to be capable of exerting an antioxidant activity by replenishing the intracellular thiol pool, e.g. reduced glutathione (GSH), clearly inhibited mERa upregulation.
Sex steroids are effective regulators of cell morphology and tissue organization, and recent evidence indicates that this is obtained through the regulatory activity of the cytoskeletal network [28] . Intriguingly, many of these regulatory actions related to cell morphology are achieved through rapid, nonclassical signaling of sex steroid receptors to kinase cascades, independently from a direct nuclear alteration of gene expression or protein synthesis. For instance, we found that the expression of mERa at the cell surface, occurring after CMP, was associated with the expression of the MAP2 cytoskeletal protein, known to be involved in microtubule assembly and neurogenesis [29] . We cannot rule out the possibility that MAP2 phosphorylation and overexpression, previously observed in E2-treated hippocampal cells [35] [36] [37] , could play a role in CMP-associated mERa expression at the cell surface. Conversely, actin microfilaments, although partially rearranged in CMP-treated neuronal cells, did not display any overlay with mERa expression, so that a role for actin filaments in mERa up-regulation should be ruled out.
We demonstrated the functional activity of the cell surface mERa by treatment of neuronal cells with E2BSA under CMPmediated stress. The ligation of mERa activates intracellular signals, increasing pERK phosphorylation and decreasing p-p38 levels. These results are in line with recent findings that support the hypothesis that mER represent functional receptors in different cell types, including blood vessel cells, lymphocytes or neuronal cells [5] . For instance, in neuronal cells, mER can affect the regulation of key proteins involved in neurotransmitter release at synapses, i.e. synapsins, via cytoskeleton [38] . We actually found that under unfavorable conditions, i.e. mimicking an inflammatory microenvironment, the up-modulation of the expression of mERa at the cell surface could represent an important controller of cell fate. In fact, we found that mERa ligation by E2BSA was capable of influence cell cytoprotection by lowering apoptosis rates and bolstering autophagic pathway. Accordingly, recent lines of evidence suggested the possible role of autophagy as cytoprotection mechanism counteracting cell demise by apoptosis in neurodegenerative disorders [39] .
In conclusion, in line with some recent literature data [40, 41] , our results highlight the importance of mERa (and estrogens) in regulating the coordinated framework of defense strategies aimed at counteracting chronic oxidative imbalance, a causative factor of neuronal cell aging and degeneration, and in determining cell fate.
Materials and Methods
Cell culture and treatments SH-SY5Y neuroblastoma cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Euroclone, Pero, Milan, Italy), and 50 mg/mL gentamicin (Sigma, St Louis, MO) in a humidified air 5% CO 2 chamber at 37uC. Cells of passage number 5-15, from ATCC, were used for all experiments to prevent any alteration of growth or response phenotype.
Primary hippocampal neurons were prepared from embryonicday-18 rat brain, according to the method of Brewer et al. [42] , slightly modified [43] . All experimental procedures were in line with the ''Ethical principles and guidelines for scientific experiments on animals'' of the Swiss Academy of Medical Sciences and national laws. After dissection, the hippocampi were treated with 2.5% trypsin and dissociated. The cells were plated in 24-well plates, containing poly-l-lysine-treated glass coverslips, in MEM, containing 10% heat-inactivated FCS (Euroclone). After 2 h, the cell culture medium was substituted with Neurobasal medium with B27 supplement (NBM/B27, Invitrogen, Carlsbad, CA), 700 ml for well. At Day-In-Vitro (DIV) 1, 5 mM arabinosylcytosine was added. Neuronal cell cultures contained less than 1% of astrocytes, as shown by glial fibrillary acidic protein staining (data not shown). Hippocampal neurons were used at DIV14 (mature neurons).
To induce protracted, tolerable oxidative stress, named chronic minimal peroxide (CMP) treatment, cells were treated with 10 nM 
Flow cytometry analysis
For evaluating cell surface expression of ER, cells were stained for 30 min at 4uC with the following antibodies (Abs): rabbit antihuman ERa MC-20 policlonal Ab, directed to the C-terminus of the ERa; mouse anti-human ERb 1531 monoclonal Ab, directed to the C-terminus of the ERb. These antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and 1 mg per sample (1610 6 cells) was used. Equal amounts of appropriate isotype controls (Santa Cruz) were used as negative controls. The primary Abs were visualized by fluorescein isothiocyanate (FITC)-conjugated or phycoerythrin (PE)-conjugated F(ab9)2 fragment secondary Abs (Abcam, Cambridge, UK). For intracellular staining, cells were fixed with 4% paraformaldehyde (PFA) by incubation for 15 min at room temperature, permeabilized with 0.1% Triton X-100 for 5 min, washed and stained as described above. Quantitative evaluation of apoptosis was performed by flow cytometry after double staining method using FITC-conjugated Annexin V (AV)/Propidium Iodide (PI) apoptosis detection kit (Marine Biological Laboratory Woods Hole, MA). Reported data are referred to AV-positive apoptotic cells. Acquisition was performed on a FACSCalibur (BD Immunocytometry Systems, San Jose, CA) and data were analyzed using the Cell Quest Pro software (BD Immunocytometry Systems).
Immunofluorescence experiments
An indirect immunofluorescence assay was developed on SH-SY5Y cells and primary hippocampal neurons, as previously described [44] . Cells were fixed with 4% PFA in PBS for 30 min at 4uC or permeabilized with acetone/methanol 1/1 (v/v) for 10 min at 4uC and then were incubated for 30 min at 25uC in the blocking buffer (2% BSA in PBS, containing 5% glycerol and 0.2% Tween 20) . After washing three times with PBS, cells were incubated for 1 h at 4uC with rabbit anti-human ERa MC-20 polyclonal Ab (Santa Cruz), mouse anti-human ERb 1531 monoclonal Ab (Santa Cruz), and mouse anti-MAP2 monoclonal Ab (Sigma). FITC-conjugated anti-mouse IgG (c-chain specific, Sigma) were then added and incubated at 4uC for 30 min. After further washings, cells were counterstained with trypan blue dye to distinguish dead cells (excluded from our analysis) from living cells. For actin microfilament detection, samples were stained with fluorescein-phalloidin (Sigma) at 37uC for 30 min. For nuclear staining, the dye Hoechst 33258 (Sigma) was used. Samples were analyzed with an Olympus U RFL microscope (Olympus, Hamburg, Germany).
Western blot analysis
Cells lysates were prepared as previously described [45] . Western blot was performed with antibodies to: LC3-II (rabbit anti-human LC3-II polyclonal Ab, Cell Signaling Technology, Beverly, MA); p-ERK1/2 (mouse anti-human monoclonal Ab, Cell Signaling); p-p38 (mouse anti-human monoclonal Ab, Cell Signaling). After incubation with peroxidase-conjugated goat antirabbit or anti-mouse IgG (Bio-Rad Laboratories, Richmond, CA, USA), the reactions were developed by SuperSignal West Pico chemiluminescent Substrate (Pierce, Rockford, IL). The membranes were re-probed with anti mouse anti-b-actin monoclonal Ab (Amersham, Gent, Belgium). Proteins were quantified by densitometry analysis of the autoradiograms (GS-700 Imaging Densitometer, Bio-Rad).
Knock down ERa by siRNA SH-SY5Y were seeded (2610 4 cells/dish) in 60 mm dish in DMEM, containing serum and antibiotics. Twenty-four hours after seeding, cells were transfected with GeneSolution siRNA (QIAGEN Sciences, Germantown, MD), according to the manufacturer's instructions, using 5 nM Smart pool siRNA ERa. As experimental control, cells were also transfected with 5 nM of non-silencing siRNA (AllStars Negative Control, QIA-GEN). After transfection, cells were treated with H 2 O 2 for five days as reported above (CMP treatment) and the effect of transfection was verified by flow cytometry analysis by using antihuman ERa MC-20 polyclonal Ab.
Statistical analyses
The two-tailed Mann-Whitney U test and x 2 test were performed. Statistical significance was set at P,0.01. Flow cytometry data were statistically evaluated using the Kolmogorov-Smirnov test [46] according to the Cell Quest Pro software guide (BD Immunocytometry Systems) and a D/s ratio $15 was accepted as significant in the experimental condition used. Data were expressed as mean 6 SD. Figure S1 mERa and filamentous actin in rat neurons. Author Contributions
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